Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane A Mitchell

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Lancet (London, England)|January 22, 2008
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugsTimothy D Warner, Jane A Mitchell
Nature Reviews. Drug Discovery|February 18, 2006
COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugsJane A Mitchell, Timothy D Warner
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2013
Reply to Ricciotti et al.: Evidence for vascular COX isoformsJane A Mitchell, Timothy D Warner
British Journal of Pharmacology|February 23, 2018
Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular systemJane A Mitchell, Nicholas S Kirkby
Clinical Science (London, England : 1979)|July 10, 2003
HIF, stretching to get control of VEGFTimothy D Warner, Jane A Mitchell
British Journal of Pharmacology|October 7, 2004
Novel role for P2X receptor activation in endothelium-dependent vasodilationLouise S Harrington, Jane A Mitchell
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 22, 2019
Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung diseasePeter M George, Jane A Mitchell
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 2004
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinicTimothy D Warner, Jane A Mitchell
Journal of Viral Hepatitis|July 2, 2013
Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virusPeter M George, Jane A Mitchell
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2003
Nonsteroidal antiinflammatory drugs inhibiting prostanoid efflux: as easy as ABC?Timothy D Warner, Jane A Mitchell
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|January 22, 2008
COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugsTimothy D Warner, Jane A Mitchell
Nature Reviews. Drug Discovery|February 18, 2006
COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugsJane A Mitchell, Timothy D Warner
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2013
Reply to Ricciotti et al.: Evidence for vascular COX isoformsJane A Mitchell, Timothy D Warner
British Journal of Pharmacology|February 23, 2018
Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular systemJane A Mitchell, Nicholas S Kirkby
Clinical Science (London, England : 1979)|July 10, 2003
HIF, stretching to get control of VEGFTimothy D Warner, Jane A Mitchell
British Journal of Pharmacology|October 7, 2004
Novel role for P2X receptor activation in endothelium-dependent vasodilationLouise S Harrington, Jane A Mitchell
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 22, 2019
Defining a pathological role for the vasculature in the development of fibrosis and pulmonary hypertension in interstitial lung diseasePeter M George, Jane A Mitchell
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 2004
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinicTimothy D Warner, Jane A Mitchell
Journal of Viral Hepatitis|July 2, 2013
Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virusPeter M George, Jane A Mitchell
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2003
Nonsteroidal antiinflammatory drugs inhibiting prostanoid efflux: as easy as ABC?Timothy D Warner, Jane A Mitchell
Pageof 15